Temporary circulatory support for cardiogenic shock
Authors:
- 21 May 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 31 (4) , 444-450
Abstract
Purpose of review: Temporary circulatory support (TCS) devices play a crucial role in stabilizing patients with refractory cardiogenic shock. They provide essential hemodynamic support and serve as a bridge to recovery, decision-making, heart transplantation, or long-term mechanical circulatory support. However, despite their increasing use, recent trials challenge their impact on survival. This review summarizes recent findings and discusses challenges in optimizing patient selection and device use. Recent findings: The intra-aortic balloon pump (IABP) remains the most used TCS device. However, evidence suggests it is ineffective as a standalone therapy. Its value may lie in combination strategies, such as pairing with VA-ECMO, to enhance ventricular unloading. Recent randomized trials on VA-ECMO, including ECLS-SHOCK, have been disappointing. They show no survival benefit in acute myocardial infarction-related cardiogenic shock. Even well conducted trials face limitations, including heterogeneous patient populations and challenges in endpoint selection, making definitive conclusions difficult. The Impella device showed promising results in the DanGer Shock trial, with reduced mortality compared to standard care. However, concerns persist about patient selection and the unexpectedly high mortality rate in the control group. Meanwhile, the role of temporary right ventricular assist devices is increasingly recognized, particularly in facilitating hemodynamic stability during left ventricular assist device implantation. Summary: TCS has revolutionized the management of cardiogenic shock, but significant challenges remain. Further research is needed to refine patient selection, improve device integration, and optimize outcomes. Emerging technologies, including biocompatible materials and artificial intelligence for device monitoring, hold promise for advancing the field. Future studies should also prioritize multicenter collaborations and real-world data to address current limitations in evidence.Keywords
This publication has 45 references indexed in Scilit:
- Thrombolysis before venoarterial ECMO for high-risk pulmonary embolism: a retrospective cohort studyIntensive Care Medicine, 2024
- Right Heart Failure with Left Ventricular Assist Devices: Preoperative, Perioperative and Postoperative Management Strategies. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESCEuropean Journal of Heart Failure, 2024
- The Intelligent Impella: Future Perspectives of Artificial Intelligence in the Setting of Impella SupportESC Heart Failure, 2024
- Right atrial collapse mimicking cardiac tamponade in a patient on veno-arterial extracorporeal membrane oxygenationIntensive Care Medicine, 2024
- Temporary Mechanical Circulatory Support for Cardiogenic Shock: Definitive Intervention or Ancillary Bridging Therapy? Letter Regarding the Article ‘What About Current Recommendations for Extracorporeal Life Support in Acute Myocardial Infarction-Associated Cardiogenic Shock: Stay or Go? or Time to Revise?’European Journal of Heart Failure, 2024
- What’s new in VA-ECMO for acute myocardial infarction-related cardiogenic shockIntensive Care Medicine, 2024
- Venoarterial extracorporeal membrane oxygenation in immunocompromised patients with cardiogenic shock: a cohort study and propensity-weighted analysisIntensive Care Medicine, 2024
- Mechanical circulatory support for cardiogenic shock: a network meta-analysis of randomized controlled trials and propensity score-matched studiesIntensive Care Medicine, 2024
- Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac ArrestJAMA, 2022
- Percutaneous versus surgical femoro-femoral veno-arterial ECMO: a propensity score matched studyIntensive Care Medicine, 2018